Shields MD - Search Results

1

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.

Chen PH, Cai L, Huffman K, Yang C, Kim J, Faubert B, Boroughs L, Ko B, Sudderth J, McMillan EA, Girard L, Chen D, Peyton M, Shields MD, Yao B, Shames DS, Kim HS, Timmons B, Sekine I, Britt R, Weber S, Byers LA, Heymach JV, Chen J, White MA, Minna JD, Xiao G, DeBerardinis RJ. Chen PH, et al. Among authors: shields md. Mol Cell. 2019 Dec 5;76(5):838-851.e5. doi: 10.1016/j.molcel.2019.08.028. Epub 2019 Sep 26. Mol Cell. 2019. PMID: 31564558 Free PMC article.

2

NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.

Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, Cobb MH. Osborne JK, et al. Among authors: shields md. Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6524-9. doi: 10.1073/pnas.1303932110. Epub 2013 Apr 3. Proc Natl Acad Sci U S A. 2013. PMID: 23553831 Free PMC article.

3

Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.

Shields MD, Chen K, Dutcher G, Patel I, Pellini B. Shields MD, et al. Int J Mol Sci. 2022 Aug 12;23(16):9006. doi: 10.3390/ijms23169006. Int J Mol Sci. 2022. PMID: 36012272 Free PMC article. Review.

4

Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.

Shields MD, Marin-Acevedo JA, Pellini B. Shields MD, et al. Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-23. doi: 10.1200/EDBK_321483. Am Soc Clin Oncol Educ Book. 2021. PMID: 33979196 Free article.

5

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.

Schlick B, Shields MD, Marin-Acevedo JA, Patel I, Pellini B. Schlick B, et al. Among authors: shields md. Curr Treat Options Oncol. 2022 Aug;23(8):1104-1120. doi: 10.1007/s11864-022-00989-7. Epub 2022 Jun 18. Curr Treat Options Oncol. 2022. PMID: 35716328 Free PMC article. Review.

6

Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.

Chen K, Shields MD, Chauhan PS, Ramirez RJ, Harris PK, Reimers MA, Zevallos JP, Davis AA, Pellini B, Chaudhuri AA. Chen K, et al. Among authors: shields md. Mol Diagn Ther. 2021 Nov;25(6):757-774. doi: 10.1007/s40291-021-00559-x. Epub 2021 Nov 1. Mol Diagn Ther. 2021. PMID: 34725800 Free PMC article. Review.

7

Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.

Shields MD, Hicks JK, Boyle TA, Haura EB, Creelan BC. Shields MD, et al. J Thorac Oncol. 2021 Mar;16(3):e15-e17. doi: 10.1016/j.jtho.2020.09.020. J Thorac Oncol. 2021. PMID: 33641722 Free article. No abstract available.

8

A systematic review and meta-analysis of selected toxicity endpoints of alpelisib.

Shields M, Mo Q, Armitage M, Sharpe SC, Costa RLB. Shields M, et al. Oncotarget. 2020 Oct 20;11(42):3793-3799. doi: 10.18632/oncotarget.27770. eCollection 2020 Oct 20. Oncotarget. 2020. PMID: 33144920 Free PMC article. Review.

9

A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.

Shields MD, Skelton WP 4th, Laber DA, Verbosky M, Ashraf N. Shields MD, et al. J Hematol. 2021 Jun;10(3):139-142. doi: 10.14740/jh837. Epub 2021 Jun 16. J Hematol. 2021. PMID: 34267852 Free PMC article.

10

Refining neoadjuvant immunotherapy for resectable lung cancer.

Shields MD, Lovly CM. Shields MD, et al. Nat Med. 2024 May 13. doi: 10.1038/s41591-024-03001-x. Online ahead of print. Nat Med. 2024. PMID: 38740995 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page